●founderNo immediate operational change, but signals both labs are aware of and publicly hedging against regulatory or safety-driven slowdowns.
●investorSuggests both labs are managing narrative risk around safety concerns, but no concrete commitments that would affect deployment timelines.
●policyWorth watching because both frontier labs are now publicly framing deceleration as contingent on global coordination, which shapes the regulatory negotiation space.